Evaluation of Quality and Bone Microarchitecture Alterations in Osteopetrosis Patients: Assessed by HR-PQCT - Top-Institutions - MDSpire

Evaluation of Quality and Bone Microarchitecture Alterations in Osteopetrosis Patients: Assessed by HR-PQCT

  • By

  • Ruotong Zhou

  • Qianqian Pang

  • Xuan Qi

  • Yushuo Wu

  • Yue Chi

  • Lijia Cui

  • Ruizhi Jiajue

  • Xiang Li

  • Mei Li

  • Yan Jiang

  • Ou Wang

  • Xiaoping Xing

  • Li Zhang

  • Weibo Xia

  • February 11, 2025

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Endocrinology
    • Metabolic Bone Disease
    • Genetics

  • #2

    Massachusetts General Hospital (MGH) / Harvard Medical School
    Massachusetts General Hospital (MGH) / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Endocrinology
    • Bone Biology
    • Genetics

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Endocrinology
    • Bone Metabolism
    • Genetics

  • #4

    NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
    NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

    Bethesda, MD

    Key Differentiators

    • Bone Biology
    • Genetics
    • Rare Diseases

Original Source(s)

Evaluation of Quality and Bone Microarchitecture Alterations in Osteopetrosis Patients: Assessed by HR-PQCT

  • by Ruotong Zhou, Qianqian Pang, Xuan Qi, Yushuo Wu, Yue Chi, Lijia Cui, Ruizhi Jiajue, Xiang Li, Mei Li, Yan Jiang, Ou Wang, Xiaoping Xing, Li Zhang, Weibo Xia

  • February 11, 2025

Related Content

Impact of Sleeve Gastrectomy on Skeletal Health: An Overlooked Concern

Incomplete Evidence of Bone Density Normalization Following Long-Term Reproductive Hormone Treatment in Men With Hypogonadotropic Hypogonadism

The Effects of the AGE Inhibitor Pyridoxamine on Bone in Older Women With Type 2 Diabetes: A Randomized Clinical Trial